Ulrika S. H. Simonsson

3.5k total citations
114 papers, 2.6k citations indexed

About

Ulrika S. H. Simonsson is a scholar working on Infectious Diseases, Pharmacology and Epidemiology. According to data from OpenAlex, Ulrika S. H. Simonsson has authored 114 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Infectious Diseases, 43 papers in Pharmacology and 21 papers in Epidemiology. Recurrent topics in Ulrika S. H. Simonsson's work include Antibiotics Pharmacokinetics and Efficacy (41 papers), Tuberculosis Research and Epidemiology (40 papers) and Pharmacogenetics and Drug Metabolism (18 papers). Ulrika S. H. Simonsson is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (41 papers), Tuberculosis Research and Epidemiology (40 papers) and Pharmacogenetics and Drug Metabolism (18 papers). Ulrika S. H. Simonsson collaborates with scholars based in Sweden, South Africa and United Kingdom. Ulrika S. H. Simonsson's co-authors include Emma Boström, Margareta Hammarlund‐Udenaes, Mats O. Karlsson, Helen McIlleron, Peter J. Smith, Sebastian G. Wicha, Justin Wilkins, Grant Langdon, Goonaseelan Pillai and Robin J. Svensson and has published in prestigious journals such as Nature Communications, American Journal of Respiratory and Critical Care Medicine and Clinical Infectious Diseases.

In The Last Decade

Ulrika S. H. Simonsson

111 papers receiving 2.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ulrika S. H. Simonsson Sweden	29	1.0k	619	544	459	431	114	2.6k
Radojka M. Savić United States	25	1.2k 1.1×	656 1.1×	729 1.3×	486 1.1×	323 0.7×	89	3.3k
Chantal Csajka Switzerland	36	1.1k 1.1×	698 1.1×	652 1.2×	617 1.3×	460 1.1×	165	4.4k
Andrew C. Hooker Sweden	21	421 0.4×	741 1.2×	475 0.9×	559 1.2×	333 0.8×	109	3.8k
Michel Tod France	35	492 0.5×	737 1.2×	564 1.0×	686 1.5×	474 1.1×	218	4.0k
Vincent Jullien France	31	1.1k 1.1×	562 0.9×	736 1.4×	279 0.6×	238 0.6×	125	3.3k
Kyung‐Sang Yu South Korea	32	729 0.7×	612 1.0×	663 1.2×	918 2.0×	704 1.6×	333	4.5k
Emanuel Raschi Italy	34	379 0.4×	566 0.9×	342 0.6×	636 1.4×	331 0.8×	169	4.1k
Julie A. Stone United States	36	1.7k 1.6×	427 0.7×	735 1.4×	515 1.1×	186 0.4×	88	3.3k
Richard Bertz United States	29	1.9k 1.8×	225 0.4×	580 1.1×	373 0.8×	774 1.8×	113	3.6k
Charlotte Kloft Germany	34	705 0.7×	1.4k 2.3×	597 1.1×	749 1.6×	268 0.6×	207	4.1k

Countries citing papers authored by Ulrika S. H. Simonsson

Since Specialization

Citations

This map shows the geographic impact of Ulrika S. H. Simonsson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ulrika S. H. Simonsson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ulrika S. H. Simonsson more than expected).

Fields of papers citing papers by Ulrika S. H. Simonsson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ulrika S. H. Simonsson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ulrika S. H. Simonsson. The network helps show where Ulrika S. H. Simonsson may publish in the future.

Co-authorship network of co-authors of Ulrika S. H. Simonsson

This figure shows the co-authorship network connecting the top 25 collaborators of Ulrika S. H. Simonsson. A scholar is included among the top collaborators of Ulrika S. H. Simonsson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ulrika S. H. Simonsson. Ulrika S. H. Simonsson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Krishnan, Nitya, et al.. (2024). A noninvasive BCG skin challenge model for assessing tuberculosis vaccine efficacy. PLoS Biology. 22(8). e3002766–e3002766.

Nyberg, Joakim, et al.. (2024). Subcutaneous Marzeptacog Alfa (Activated) for On‐Demand Treatment of Bleeding Events in Subjects With Hemophilia A or B With Inhibitors. Clinical Pharmacology & Therapeutics. 115(3). 498–505. 1 indexed citations

Moan, Natacha Le, et al.. (2024). Model-Based Interspecies Scaling for Predicting Human Pharmacokinetics of CB 4332, a Complement Factor I Protein. Journal of Pharmaceutical Sciences. 113(9). 2895–2903. 1 indexed citations

Wijk, Rob C. van, et al.. (2023). Model‐informed pediatric dose selection of marzeptacog alfa (activated): An exposure matching strategy. CPT Pharmacometrics & Systems Pharmacology. 12(7). 977–987. 4 indexed citations

Phillips, Patrick, Caryn M. Upton, Jakko van Ingen, et al.. (2023). Early bactericidal activity studies for pulmonary tuberculosis: A systematic review of methodological aspects. International Journal of Antimicrobial Agents. 61(5). 106775–106775. 8 indexed citations

Svensson, Robin J., Elin M. Svensson, Stephen H. Gillespie, et al.. (2023). Combined quantitative tuberculosis biomarker model for time-to-positivity and colony forming unit to support tuberculosis drug development. Frontiers in Pharmacology. 14. 1067295–1067295. 5 indexed citations

Svensson, Elin M., et al.. (2023). Model-based analysis of bactericidal activity and a new dosing strategy for optimised-dose rifampicin. International Journal of Antimicrobial Agents. 61(6). 106813–106813. 1 indexed citations

Jager, Veronique de, Nikhil Gupte, Sílvia Nunes, et al.. (2022). Early Bactericidal Activity of Meropenem plus Clavulanate (with or without Rifampin) for Tuberculosis: The COMRADE Randomized, Phase 2A Clinical Trial. American Journal of Respiratory and Critical Care Medicine. 205(10). 1228–1235. 23 indexed citations

Sturkenboom, Marieke G. G., et al.. (2022). Model-Informed Precision Dosing of Linezolid in Patients with Drug-Resistant Tuberculosis. Pharmaceutics. 14(4). 753–753. 11 indexed citations

10.

Fredrikson, Mats, Björn Carlsson, Ulrika S. H. Simonsson, et al.. (2022). Safety and pharmacokinetics-pharmacodynamics of a shorter tuberculosis treatment with high-dose pyrazinamide and rifampicin: a study protocol of a phase II clinical trial (HighShort-RP). BMJ Open. 12(3). e054788–e054788. 3 indexed citations

11.

Wijk, Rob C. van, Dirk‐Jan van den Berg, Jeremy Liu, et al.. (2020). Anti‐tuberculosis effect of isoniazid scales accurately from zebrafish to humans. British Journal of Pharmacology. 177(24). 5518–5533. 11 indexed citations

12.

Wicha, Sebastian G., et al.. (2020). Translational Model‐Informed Approach for Selection of Tuberculosis Drug Combination Regimens in Early Clinical Development. Clinical Pharmacology & Therapeutics. 108(2). 274–286. 9 indexed citations

13.

Wicha, Sebastian G., Robin J. Svensson, Stephen H. Gillespie, et al.. (2018). Forecasting Clinical Dose–Response From Preclinical Studies in Tuberculosis Research: Translational Predictions With Rifampicin. Clinical Pharmacology & Therapeutics. 104(6). 1208–1218. 21 indexed citations

14.

Chen, Chunli, et al.. (2018). Comparisons of Analysis Methods for Assessment of Pharmacodynamic Interactions Including Design Recommendations. The AAPS Journal. 20(4). 77–77. 10 indexed citations

15.

Nyberg, Joakim, Trine Meldgaard Lund, Sten Rasmussen, et al.. (2016). A Pharmacokinetic-Pharmacodynamic Model of Morphine Exposure and Subsequent Morphine Consumption in Postoperative Pain. Pharmaceutical Research. 33(5). 1093–1103. 12 indexed citations

16.

Norberg, Åke, et al.. (2015). A Recirculatory Model for Pharmacokinetics and the Effects on Bispectral Index After Intravenous Infusion of the Sedative and Anesthetic AZD3043 in Healthy Volunteers. Anesthesia & Analgesia. 121(4). 904–913. 9 indexed citations

17.

Zvada, Simbarashe, Paolo Denti, Frederick A. Sirgel, et al.. (2013). Moxifloxacin Population Pharmacokinetics and Model-Based Comparison of Efficacy between Moxifloxacin and Ofloxacin in African Patients. Antimicrobial Agents and Chemotherapy. 58(1). 503–510. 35 indexed citations

18.

Simonsson, Ulrika S. H., Stanko Skrtic, Hans Lennernäs, & Gudmundur Johannsson. (2012). Intercurrent Illness Dose Regimen in Adrenal Insufficiency with a Dual Release Hydrocortisone Formulation Derived from Population Pharmacokinetic Modelling. 15th International & 14th European Congress of Endocrinology. 29. 2 indexed citations

19.

Simonsson, Ulrika S. H., et al.. (2011). Modelling of pain intensity and informative dropout in a dental pain model after naproxcinod, naproxen and placebo administration. British Journal of Clinical Pharmacology. 71(6). 899–906. 17 indexed citations

20.

Silber, Hanna E., Nicolas Frey, Ronald Gieschke, et al.. (2007). An Integrated Glucose‐Insulin Model to Describe Oral Glucose Tolerance Test Data in Type 2 Diabetics. The Journal of Clinical Pharmacology. 47(10). 1244–1255. 61 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact